ARS Pharmaceuticals, Inc. (SPRY) EBITDA
ARS Pharmaceuticals, Inc. (SPRY) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$61.47M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$60.15M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$53.19M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$47.61M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$61.47M | (m) | $33.66M | (m) | $0.00* | -$60.93M* | (m) | $4.70M | $77.58M | (m) |
|---|
| 2026-03-31 | Reported | (m) | -$60.15M | (m) | $22.68M | (m) | $0.00 | -$44.95M | (m) | $4.34M | $72.20M | (m) |
|---|
| 2025-09-30 | Reported | (m) | -$53.19M | (m) | $32.50M | (m) | $197.00K* | -$47.05M* | (m) | $2.75M | $74.75M | (m) |
|---|
| 2025-06-30 | Reported | (m) | -$47.61M | (m) | $15.72M | (m) | $51.00K* | -$39.59M* | (m) | $4.04M | $54.31M | (m) |
|---|
| 2025-03-31 | Reported | (m) | -$37.18M | (m) | $7.97M | (m) | $91.00K | -$40.74M | (m) | $2.95M | $41.10M | (m) |
|---|
| 2024-09-30 | Reported | (m) | -$21.75M | (m) | $2.07M | (m) | $140.00K* | -$14.47M* | (m) | $4.42M | $19.28M | (m) |
|---|
| 2024-06-30 | Reported | (m) | -$15.34M | (m) | $500.00K | (m) | $38.00K* | -$7.28M* | (m) | $6.90M | $8.94M | (m) |
|---|
| 2024-03-31 | Reported | (m) | -$13.19M | (m) | $0.00 | (m) | $83.00K | -$6.71M | (m) | $5.23M | $7.96M | (m) |
|---|
| 2023-09-30 | Reported | (m) | -$17.98M | (m) | $0.00 | (m) | $43.00K* | -$12.76M* | (m) | $3.00M | $14.98M | (m) |
|---|
| 2023-06-30 | Reported | (m) | -$20.60M | (m) | $10.00K | (m) | $30.00K* | -$16.67M* | (m) | $7.31M | $181.00K | (m) |
|---|
| 2023-03-31 | Reported | (m) | -$18.71M | (m) | $20.00K | (m) | $193.00K | -$12.43M | (m) | $6.55M | $337.00K | (m) |
|---|
| 2022-09-30 | Reported | (m) | -$6.63M | (m) | $189.00K | (m) | $30.00K* | -$5.68M* | (m) | $3.89M | (m) | (m) |
|---|
| 2022-06-30 | Reported | (m) | -$6.34M | (m) | $464.00K | (m) | $22.00K* | -$6.97M* | (m) | $4.35M | (m) | (m) |
|---|
| 2022-03-31 | Reported | (m) | -$7.10M | (m) | $663.00K | (m) | $21.00K | -$6.92M | (m) | $5.42M | (m) | (m) |
|---|
| 2021-09-30 | Reported | (m) | -$22.68M | (m) | (m) | (m) | $87.00K* | -$19.12M* | (m) | $15.64M | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$24.51M | (m) | (m) | (m) | $700.00K* | -$14.13M* | (m) | $17.75M | (m) | (m) |
|---|
| 2021-03-31 | Reported | (m) | -$18.89M | (m) | (m) | (m) | $35.00K | -$12.20M | (m) | $12.24M | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$8.11M | (m) | (m) | (m) | $632.00K* | -$7.03M* | (m) | $6.20M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$6.46M | (m) | (m) | (m) | $5.00K* | -$5.44M* | (m) | $5.13M | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$5.24M | (m) | (m) | (m) | $33.00K | -$7.63M | (m) | $4.41M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$179.45M | (m) | $84.28M | (m) | $339.00K | -$170.87M | (m) | $13.18M | $230.12M | -$80.00K |
|---|
| 2024-12-31 | Reported | (m) | -$3.08M | (m) | $89.15M | (m) | $563.00K | $13.55M | (m) | $19.58M | $71.67M | $288.00K |
|---|
| 2023-12-31 | Reported | (m) | -$67.52M | (m) | $30.00K | (m) | $175.00K | -$59.27M | $0.00 | $20.27M | $47.28M | $0.00 |
|---|
| 2022-12-31 | Reported | (m) | -$35.52M | (m) | $1.32M | (m) | $199.00K | -$40.08M | (m) | $18.38M | $603.00K | $0.00 |
|---|
| 2021-12-31 | Reported | (m) | -$19.45M | (m) | $5.51M | (m) | $55.00K | -$17.56M | (m) | $20.27M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | (m) | -$32.92M | (m) | (m) | (m) | $917.00K | -$31.20M | (m) | $24.58M | (m) | $0.00 |
|---|